GENEVA, June 26 -- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. filed a patent application (CN2025/139063) for “GLP-1R/GIPR/GCGR TRIPLE AGONIST AND USE THEREOF”. With publication no. WO/2026/119079, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/605
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....